Literature DB >> 27002420

Correlates of Executive Functions in Multiple Sclerosis Based on Structural and Functional MR Imaging: Insights from a Multicenter Study.

Marisa Koini1, Massimo Filippi1, Maria A Rocca1, Tarek Yousry1, Olga Ciccarelli1, Gioacchino Tedeschi1, Antonio Gallo1, Stefan Ropele1, Paola Valsasina1, Gianna Riccitelli1, Dusan Damjanovic1, Nils Muhlert1, Laura Mancini1, Franz Fazekas1, Christian Enzinger1.   

Abstract

Purpose To study the concomitant use of structural and functional magnetic resonance (MR) imaging correlates to explain information processing speed (IPS) and executive function (EF) in multiple sclerosis (MS). Materials and Methods Local ethics committee approval was obtained at all sites for this prospective, multicenter study. All subjects provided written informed consent. Twenty-six patients with relapsing-remitting MS and 32 healthy control subjects from four centers underwent structural and functional MR imaging, including a go/no-go task and neuropsychological assessment. Subtests of the Brief Repeatable Battery of Neuropsychological Tests, the Wisconsin Card Sorting Test, and the performance with the functional MR imaging paradigm were used as estimates of IPS and EF. Activation of the thalamus and the inferior frontal gyrus (pars triangularis), thalamic volume, T2 lesion load, and age were used to explain IPS and EF in regression models. Results Compared with control subjects, patients showed increased activation in a frontoparietal network, including both thalami, during the execution of the go/no-go task. Patients had decreased thalamic volume (P < .001). Among tested variables, thalamic volume (β = 0.606, P = .001), together with thalamic activation (β = -0.410, P = .022), were the best predictors of IPS and EF and helped explain 52.7% of the variance in IPS and EF. Conclusion This study highlights the potential of the combined use of functional and morphologic parameters to explain IPS and EF in patients with relapsing-remitting MS and confirms the central role of the thalamus as a relay station in executive functioning. (©) RSNA, 2016.

Entities:  

Mesh:

Year:  2016        PMID: 27002420     DOI: 10.1148/radiol.2016151809

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  10 in total

Review 1.  The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.

Authors:  Kedar R Mahajan; Daniel Ontaneda
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

2.  The role of the thalamus and hippocampus in episodic memory performance in patients with multiple sclerosis.

Authors:  Katherine A Koenig; Stephen M Rao; Mark J Lowe; Jian Lin; Ken E Sakaie; Lael Stone; Robert A Bermel; Bruce D Trapp; Micheal D Phillips
Journal:  Mult Scler       Date:  2018-03-07       Impact factor: 6.312

Review 3.  Imaging as an Outcome Measure in Multiple Sclerosis.

Authors:  Daniel Ontaneda; Robert J Fox
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

Review 4.  Mind the gap: from neurons to networks to outcomes in multiple sclerosis.

Authors:  Declan T Chard; Adnan A S Alahmadi; Bertrand Audoin; Thalis Charalambous; Christian Enzinger; Hanneke E Hulst; Maria A Rocca; Àlex Rovira; Jaume Sastre-Garriga; Menno M Schoonheim; Betty Tijms; Carmen Tur; Claudia A M Gandini Wheeler-Kingshott; Alle Meije Wink; Olga Ciccarelli; Frederik Barkhof
Journal:  Nat Rev Neurol       Date:  2021-01-12       Impact factor: 42.937

5.  Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial.

Authors:  Dennis Chan; Sophie Binks; Jennifer M Nicholas; Chris Frost; M Jorge Cardoso; Sebastien Ourselin; David Wilkie; Richard Nicholas; Jeremy Chataway
Journal:  Lancet Neurol       Date:  2017-06-07       Impact factor: 44.182

6.  Study protocol: improving cognition in people with progressive multiple sclerosis: a multi-arm, randomized, blinded, sham-controlled trial of cognitive rehabilitation and aerobic exercise (COGEx).

Authors:  Anthony Feinstein; Maria Pia Amato; Giampaolo Brichetto; Jeremy Chataway; Nancy Chiaravalloti; Ulrik Dalgas; John DeLuca; Peter Feys; Massimo Filippi; Jennifer Freeman; Cecilia Meza; Matilde Inglese; Robert W Motl; Maria Assunta Rocca; Brian M Sandroff; Amber Salter; Gary Cutter
Journal:  BMC Neurol       Date:  2020-05-22       Impact factor: 2.474

7.  Identification of Cortical and Subcortical Correlates of Cognitive Performance in Multiple Sclerosis Using Voxel-Based Morphometry.

Authors:  Jordi A Matías-Guiu; Ana Cortés-Martínez; Paloma Montero; Vanesa Pytel; Teresa Moreno-Ramos; Manuela Jorquera; Miguel Yus; Juan Arrazola; Jorge Matías-Guiu
Journal:  Front Neurol       Date:  2018-10-29       Impact factor: 4.003

8.  D-KEFS ST Failure Identifies Multiple Sclerosis Patients With Worse Objective and Self-Perceived Physical and Cognitive Disability.

Authors:  Alice Riccardi; Marco Puthenparampil; Francesca Rinaldi; Mario Ermani; Paola Perini; Paolo Gallo
Journal:  Front Psychol       Date:  2019-01-24

9.  The Contribution of Various MRI Parameters to Clinical and Cognitive Disability in Multiple Sclerosis.

Authors:  Eszter Tóth; Péter Faragó; András Király; Nikoletta Szabó; Dániel Veréb; Krisztián Kocsis; Bálint Kincses; Dániel Sandi; Krisztina Bencsik; László Vécsei; Zsigmond Tamás Kincses
Journal:  Front Neurol       Date:  2019-01-23       Impact factor: 4.003

10.  Robustness of Brain Structural Networks Is Affected in Cognitively Impaired MS Patients.

Authors:  Hamza Farooq; Christophe Lenglet; Flavia Nelson
Journal:  Front Neurol       Date:  2020-11-19       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.